Syncom Formulations (India) informs about disclosure

30 Sep 2021 Evaluate

Syncom Formulations (India) has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vijay Shankarlal Bankda & PACs.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

11.95 -0.26 (-2.13%)
23-Jan-2026 13:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1636.30
Dr. Reddys Lab 1239.20
Cipla 1339.75
Zydus Lifesciences 884.65
Lupin 2140.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×